Literature DB >> 23178496

Cells of origin for cancer: an updated view from prostate cancer.

L Xin1.   

Abstract

The cells of origin for cancer are the cells within tissues that serve as the target for transformation. Understanding the nature of these cells will benefit disease prevention, diagnosis and prognosis. During the past decade, much progress has been made in understanding the cellular origin for prostate cancer. This review aims to summarize the previous findings, describe the most recent results and discuss some controversies and unresolved issues in this field.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23178496      PMCID： PMC3740004          DOI： 10.1038/onc.2012.541

Source DB:  PubMed          Journal:  Oncogene        ISSN： 0950-9232            Impact factor:   9.867


  81 in total

1.  Lineage enforcement by inductive mesenchyme on adult epithelial stem cells across developmental germ layers.

Authors:  Renea A Taylor; Hong Wang; Sarah E Wilkinson; Michelle G Richards; Kara L Britt; François Vaillant; Geoffrey J Lindeman; Jane E Visvader; Gerald R Cunha; Justin St John; Gail P Risbridger
Journal:  Stem Cells       Date:  2009-12       Impact factor: 6.277

2.  An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB.

Authors:  Junxia Min; Alexander Zaslavsky; Giuseppe Fedele; Sara K McLaughlin; Elizabeth E Reczek; Thomas De Raedt; Isil Guney; David E Strochlic; Laura E Macconaill; Rameen Beroukhim; Roderick T Bronson; Sandra Ryeom; William C Hahn; Massimo Loda; Karen Cichowski
Journal:  Nat Med       Date:  2010-02-14       Impact factor: 53.440

3.  ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells.

Authors:  Yang Zong; Li Xin; Andrew S Goldstein; Devon A Lawson; Michael A Teitell; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-10       Impact factor: 11.205

4.  Basal epithelial stem cells are efficient targets for prostate cancer initiation.

Authors:  Devon A Lawson; Yang Zong; Sanaz Memarzadeh; Li Xin; Jiaoti Huang; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-25       Impact factor: 11.205

5.  Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate.

Authors:  Brett S Carver; Jennifer Tran; Anuradha Gopalan; Zhenbang Chen; Safa Shaikh; Arkaitz Carracedo; Andrea Alimonti; Caterina Nardella; Shohreh Varmeh; Peter T Scardino; Carlos Cordon-Cardo; William Gerald; Pier Paolo Pandolfi
Journal:  Nat Genet       Date:  2009-04-26       Impact factor: 38.330

6.  Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers.

Authors:  Elgene Lim; François Vaillant; Di Wu; Natasha C Forrest; Bhupinder Pal; Adam H Hart; Marie-Liesse Asselin-Labat; David E Gyorki; Teresa Ward; Audrey Partanen; Frank Feleppa; Lily I Huschtscha; Heather J Thorne; Stephen B Fox; Max Yan; Juliet D French; Melissa A Brown; Gordon K Smyth; Jane E Visvader; Geoffrey J Lindeman
Journal:  Nat Med       Date:  2009-08-02       Impact factor: 53.440

7.  Low-density Taqman miRNA array reveals miRNAs differentially expressed in prostatic stem cells and luminal cells.

Authors:  Li Zhang; Wenping Zhao; Joseph M Valdez; Chad J Creighton; Li Xin
Journal:  Prostate       Date:  2010-02-15       Impact factor: 4.104

Review 8.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

9.  A luminal epithelial stem cell that is a cell of origin for prostate cancer.

Authors:  Xi Wang; Marianna Kruithof-de Julio; Kyriakos D Economides; David Walker; Hailong Yu; M Vivienne Halili; Ya-Ping Hu; Sandy M Price; Cory Abate-Shen; Michael M Shen
Journal:  Nature       Date:  2009-09-09       Impact factor: 49.962

10.  Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis.

Authors:  Jennifer C King; Jin Xu; John Wongvipat; Haley Hieronymus; Brett S Carver; David H Leung; Barry S Taylor; Chris Sander; Robert D Cardiff; Suzana S Couto; William L Gerald; Charles L Sawyers
Journal:  Nat Genet       Date:  2009-04-26       Impact factor: 38.330
View more
  30 in total

1.  ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer.

Authors:  Chen-Ying Liu; Tong Yu; Yuji Huang; Long Cui; Wanjin Hong
Journal:  J Biol Chem       Date:  2017-04-13       Impact factor: 5.157

Review 2.  Prostate epithelial stem and progenitor cells.

Authors:  Oh-Joon Kwon; Li Xin
Journal:  Am J Clin Exp Urol       Date:  2014-10-02

3.  Adiponectin inhibits VEGF-A in prostate cancer cells.

Authors:  Qiruo Gao; Junhua Zheng; Xudong Yao; Bo Peng
Journal:  Tumour Biol       Date:  2015-01-15

4.  Establishment and characterization of a prostate cancer cell line from a prostatectomy specimen for the study of cellular interaction.

Authors:  Ruoxiang Wang; Gina C-Y Chu; Xudong Wang; Jason B Wu; Peizhen Hu; Asha S Multani; Sen Pathak; Haiyen E Zhau; Leland W K Chung
Journal:  Int J Cancer       Date:  2019-05-10       Impact factor: 7.396

Review 5.  Prostate Luminal Progenitor Cells in Development and Cancer.

Authors:  Dingxiao Zhang; Shuhong Zhao; Xinyun Li; Jason S Kirk; Dean G Tang
Journal:  Trends Cancer       Date:  2018-10-01

6.  Prostatic inflammation enhances basal-to-luminal differentiation and accelerates initiation of prostate cancer with a basal cell origin.

Authors:  Oh-Joon Kwon; Li Zhang; Michael M Ittmann; Li Xin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-23       Impact factor: 11.205

7.  Luminal cells are favored as the cell of origin for prostate cancer.

Authors:  Zhu A Wang; Roxanne Toivanen; Sarah K Bergren; Pierre Chambon; Michael M Shen
Journal:  Cell Rep       Date:  2014-08-28       Impact factor: 9.423

8.  Stem Cell Antigen-1 Identifies a Distinct Androgen-Independent Murine Prostatic Luminal Cell Lineage with Bipotent Potential.

Authors:  Oh-Joon Kwon; Li Zhang; Li Xin
Journal:  Stem Cells       Date:  2015-10-27       Impact factor: 6.277

9.  VEGF-activated miR-144 regulates autophagic survival of prostate cancer cells against Cisplatin.

Authors:  Feng Liu; Jihong Wang; Qiang Fu; Xinru Zhang; Ying Wang; Jialin Liu; Jianwen Huang; Xiangguo Lv
Journal:  Tumour Biol       Date:  2015-11-13

Review 10.  Prostate Stem Cells and Cancer Stem Cells.

Authors:  Jia J Li; Michael M Shen
Journal:  Cold Spring Harb Perspect Med       Date:  2019-06-03       Impact factor: 6.915
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.